MAGELLAN LONGEVITY
HomeResearchStudy library › Can Serum Gamma-Glutamyl Transferase Predict All-Cause Mortality in…
Study summary · Pain, nerves & musculoskeletal medicine

Can serum gamma-glutamyl transferase (GGT) predict all-cause mortality in hypertensive patients?

In one paragraph

Serum Gamma-Glutamyl Transferase, a cohort study (Cureus 2024, PMID 39347158) — during a median follow-up of 13.9 years, 716 deaths occurred (360 men, 356 women), with a mortality rate of 25.5 deaths per 1,000 person-years. The abstract for Serum Gamma-Glutamyl Transferase states no limitations.

Source: Cureus 2024, PMID 39347158 ↗ · Research map · How Magellan grades evidence · evidence confidence: medium

Cureus · 2024 · PMID 39347158 · DOI 10.7759/cureus.68247

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Higher serum GGT levels are associated with an increased risk of all-cause mortality in hypertensive men.

The question

Can serum gamma-glutamyl transferase (GGT) predict all-cause mortality in hypertensive patients?

What they tested

The study hypothesized that serum GGT levels would be associated with all-cause mortality in hypertensive patients.

How they did it

The study analyzed 1,101 female (average age 69 years) and 916 male (average age 67 years) hypertensive participants from the Nomura cohort study. Participants were followed for a median of 13.9 years, and Cox proportional hazards models were used to calculate adjusted hazard ratios for mortality risk.

What they found

During a median follow-up of 13.9 years, 716 deaths occurred (360 men, 356 women), with a mortality rate of 25.5 deaths per 1,000 person-years. Male participants with serum GGT levels of 42-86 IU/L had a 64% increased risk of all-cause mortality (HR: 1.64), and those with GGT levels of 87 IU/L or higher had a 93% elevated risk (HR: 1.93) compared to men with GGT levels below 19 IU/L. This association was more pronounced in men than in women, with a significant interaction between gender and baseline serum GGT (p = 0.020).

Increased Risk of All-Cause Mortality in Hypertensive Men by GGT Level
Values shown: Increased Risk (%)
GGT 42-86 IU/L64
GGT ">= 87 IU/L"93

Compared to men with GGT levels below 19 IU/L, those with GGT levels of 42-86 IU/L had a 64% increased risk of all-cause mortality, and those with GGT levels of 87 IU/L or higher had a 93% increased risk.

What it means

Irregular GGT levels are notably correlated with overall mortality in Japanese individuals with hypertension. GGT activity is a critical biomarker for predicting long-term survival, especially in older males.

Limitations

The abstract does not explicitly state any limitations of the study.

Where the published abstract does not list limitations, we say so rather than inventing them. Read the full paper on PubMed before drawing conclusions.

“GGT activity turns out to be a critical biomarker for predicting long-term survival”— from the published abstract, Cureus 2024

The paper at a glance

TitleCan Serum Gamma-Glutamyl Transferase Predict All-Cause Mortality in Hypertensive Patients?
JournalCureus
Year2024
PMID39347158 ↗
DOI10.7759/cureus.68247 ↗
TopicPain, nerves & musculoskeletal medicine

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

GGT Liver-Health Test

Large prospective cohorts and meta-analyses consistently link higher serum GGT, even within the reference range, to increased all-cause and cardiovascular mortality, incident hypertension, type 2 diabetes, metabolic syndrome and fatty liver, and some cancers, associations frequently interpreted through GGT's…

GGT Liver-Health Test

Gamma-glutamyltransferase (GGT) is a cell-surface enzyme found mainly in the liver that initiates the…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). Can serum gamma-glutamyl transferase (GGT) predict all-cause mortality in hypertensive patients? [Plain-English summary of Cureus 2024, PMID 39347158, DOI 10.7759/cureus.68247]. Magellan Longevity. https://magellanlongevity.com/study/d39347158.html
BibTeX
@misc{magellan_d39347158, title = {Can serum gamma-glutamyl transferase (GGT) predict all-cause mortality in hypertensive patients?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/d39347158.html}}, note = {Plain-English summary of PubMed PMID 39347158; DOI 10.7759/cureus.68247; Cureus 2024. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/d39347158.html

Related studies in the Magellan library

All 14 Magellan summaries on pain, nerves & musculoskeletal medicine →

How this summary was made. Every section above restates what the published abstract of PMID 39347158 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.